Sotera Health Company
Stock Forecast, Prediction & Price Target
Sotera Health Company (SHC) stock Price Target by analysts
$16.5
Potential upside: 1.16%
Sotera Health Company price prediction
What is Sotera Health Company stock analysts` prediction?
Sotera Health Company stock forecast: Based on 1 Wall Street analysts` predicted price targets for Sotera Health Company in the last 3 months, the avarage price target is $16.5, with a high forecast of $NaN. The average price target represents a 1.16% change from the last price of $16.31.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Sotera Health Company stock Price Target by analysts
Full breakdown of analysts given Sotera Health Company price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Windley Jefferies | 0% 0/4 | 10 months ago | $15 -8.03% downside | $12.98 | StreetInsider | Previous targets (3) |
David Windley Jefferies | 0% 0/4 | 11 months ago | $18 10.36% upside | $15.27 | StreetInsider | Previous targets (3) |
Luke Sergott Barclays | 0% 0/3 | about 1 year ago | $17 4.23% upside | $14.22 | TheFly | Previous targets (2) |
David Windley Jefferies | 0% 0/4 | over 1 year ago | $14.5 -11.09% downside | $11.98 | StreetInsider | Previous targets (3) |
Jason Bednar Piper Sandler | 0% 0/1 | over 1 year ago | $13 -20.29% downside | $10.91 | StreetInsider | Previous targets (0) |
Sean Dodge RBC Capital | 0% 0/1 | over 1 year ago | $17 4.23% upside | $10.91 | StreetInsider | Previous targets (0) |
Luke Sergott Barclays | 0% 0/3 | over 1 year ago | $14 -14.16% downside | $11.62 | TheFly | Previous targets (2) |
David Windley Jefferies | 0% 0/4 | over 1 year ago | $15.5 -4.96% downside | $11.94 | StreetInsider | Previous targets (3) |
Matthew Mishan Loop Capital Markets | 0% 0/1 | over 2 years ago | $24 47.14% upside | $18.59 | Benzinga | Previous targets (0) |
Luke Sergott Barclays | 0% 0/3 | over 2 years ago | $22 34.88% upside | $17.25 | StreetInsider | Previous targets (2) |
Mike Polark Wolfe Research | 0% 0/1 | over 2 years ago | $25 53.28% upside | $17.25 | TheFly | Previous targets (0) |
Unknown Goldman Sachs | N/A | almost 3 years ago | $8 -50.95% downside | $8.12 | Benzinga | N/A |
Unknown Barclays | N/A | almost 3 years ago | $6 -63.21% downside | $7.14 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $22 34.88% upside | $18.66 | Benzinga | N/A |
Sotera Health Company Financial Estimates
Sotera Health Company Revenue Estimates
Sotera Health Company EBITDA Estimates
Sotera Health Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $931.47M N/A | $1.00B 7.75% | $1.04B 4.54% | Avg: $1.17B Low: $1.15B High: $1.18B avg. 12.24% | Avg: $1.26B Low: $1.25B High: $1.27B avg. 7.23% | ||
Net Income
% change YoY
| $116.88M N/A | $-233.57M -299.83% | $51.37M 121.99% | Avg: $138.36M Low: $108.82M High: $181.26M avg. 169.31% | Avg: $172.60M Low: $144.44M High: $195.42M avg. 24.74% | ||
EBITDA
% change YoY
| $335.71M N/A | $317.73M -5.35% | $420.19M 32.24% | Avg: $458.39M Low: $450.62M High: $462.28M avg. 9.09% | Avg: $491.57M Low: $487.27M High: $495.26M avg. 7.23% | ||
EPS
% change YoY
| $0.41 N/A | -$0.83 -302.43% | $0.18 121.68% | Avg: $0.49 Low: $0.38 High: $0.64 avg. 170.03% | Avg: $0.6 Low: $0.51 High: $0.69 avg. 23.44% | ||
Operating Expenses
% change YoY
| $261.93M N/A | $308.65M 17.83% | $300.46M -2.65% | Avg: $239.01M Low: $234.96M High: $241.04M avg. -20.45% | Avg: $256.31M Low: $254.07M High: $258.24M avg. 7.23% | ||
FAQ
What is Sotera Health Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 97.03% in 2025-2026.
We have gathered data from 5 analysts. Their low estimate is 108.82M, average is 138.36M and high is 181.26M.
What is Sotera Health Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.73% in 2025-2026.
We have gathered data from 6 analysts. Their low revenue estimate is $1.15B, average is $1.17B and high is $1.18B.
What is Sotera Health Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 96.73% in 2025-2026.
We have gathered data from 5 analysts. Their low earnings per share estimate is $0.38, average is $0.49 and high is $0.64.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Sotera Health Company stock. The most successful analyst is David Windley.